Drug Trial Radar · NCT07775924
A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus
Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
259
Planned (sponsor's estimate)
Start
Sep 29, 2026
Primary completion
Nov 22, 2028
Study completion Feb 13, 2030
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Aug 20, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the safety and efficacy of GIA632 in participants with moderate to severe cutaneous lichen planus (cLP).
Conditions
- Cutaneous Lichen Planus
Interventions
PlaceboDrug
Matching placebo
GIA632Drug
GIA632 administered according to the assigned study treatment regimen.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants achieving an Investigator Global Assessment (IGA) responseTime frame: Week 16
Locations
27 sites in 4 countries. Site status is shown where the registry gives one.
Cahaba Derm and skin hlth ctr 27
Birmingham, Alabama · Recruiting
First OC Dermatology
Fountain Valley, California · Recruiting
Encore Medical Research
Hollywood, Florida · Recruiting
Miami Derm and Laser Institute
Miami, Florida · Recruiting
Global Clinical Professionals
St. Petersburg, Florida · Recruiting
Skin Care Physicians Of Georgia
Macon, Georgia · Recruiting
Dawes Fretzin Clinical Rea Group
Indianapolis, Indiana · Recruiting
Essential Medical Research
Overland Park, Kansas · Recruiting
Louisiana Dermatology Associates
Baton Rouge, Louisiana · Recruiting
Delricht Research
New Orleans, Louisiana · Recruiting
Uni Of Michigan Health System
Ann Arbor, Michigan · Recruiting
Hamzavi Dermatology
Fort Gratiot, Michigan · Recruiting
Minnesota Clinical Study Center
New Brighton, Minnesota · Recruiting
MediSearch Clinical Trials
Saint Joseph, Missouri · Recruiting
Skin Specialists PC
Omaha, Nebraska · Recruiting
Bellaire Dermatology Associates
Bellaire, Texas · Recruiting
NextGen Clinical Research and Innovation Inc-Network
Mansfield, Texas · Recruiting
Austin Inst for Clinical Research
Pflugerville, Texas · Recruiting
RFSA Dermatology
San Antonio, Texas · Recruiting
Novartis Investigative Site
Sydney, New South Wales, Australia · Recruiting
Novartis Investigative Site
Waitara, New South Wales, Australia · Recruiting
Novartis Investigative Site
Melbourne, Victoria, Australia · Recruiting
Novartis Investigative Site
London, Ontario, Canada · Recruiting
Novartis Investigative Site
Toronto, Ontario, Canada · Recruiting
Novartis Investigative Site
Beijing, China · Recruiting
Novartis Investigative Site
Shanghai, China · Recruiting
Novartis Investigative Site
Tianjin, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.